Quantcast
Last updated on April 16, 2014 at 6:41 EDT

Latest squamous cell carcinoma Stories

2011-01-25 12:50:20

MicroRNAs (miRNAs) regulate gene expression by mainly binding to the 3"²-UTR of target mRNAs, leading to mRNA degradation or translation inhibition. Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies in China. Many studies have reported the miRNA expression profiles in Barrett's esophagus and esophageal adenocarcinoma. However, the pathobiological significance of aberrant miRNA expression in human ESCC has not been well documented. A research article to be...

2011-01-24 13:59:00

BOCA RATON, Fla., Jan. 24, 2011 /PRNewswire/ -- Sensus Healthcare has entered into a strategic partnership with Flagship Solutions Group in an effort to merge joint interests in IT solutions for the medical field and meet the underserved needs of the dermatology and oncology practices in the United States and the global arena. As an IBM Premier Business Partner and a certified IBM Dynamic Infrastructure Partner, Flagship has attained a prestigious status which fewer than five percent of all...

2011-01-24 13:21:00

BOCA RATON, Fla., Jan. 24, 2011 /PRNewswire/ -- Sensus Healthcare is pleased to announce its Sensus Skin Solutions(TM) line of professional skin care products to be exclusively offered by our physician partners. (Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO ) Cases of skin cancer are on the rise and are dramatically escalating as the population ages. Sensus is taking new aim at skin cancer(SM) in innovative ways. On one front, we are incorporating state-of-the-art mobile...

2011-01-24 13:20:00

BOCA RATON, Fla., Jan. 24, 2011 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 69th Annual American Academy of Dermatology Meeting in New Orleans, LA on February 4-8, 2011. Visit booth #3921 to learn about the SRT-100(TM) low-dose non-invasive superficial radiotherapy (SRT) non-melanoma skin cancer therapy product line, the Sensus Skin Solutions(TM) professional skin care cosmetics line featuring innovative natural skin care and protection...

2011-01-10 14:51:40

Squamous cell carcinoma (SCC) is a common type of skin cancer. In this paper, Leif Ellisen and colleagues at Mass General Hospital investigated the p53-related proteins p63 and p73 in SCC cells, and discovered a feedback loop between p63, microRNAs (miRs), and p73. In a model of SCC, they found that inhibiting one of these miRs decreased tumor growth and made the cells more sensitive to chemotherapy, highlighting a new potential therapeutic target. Squamous cell carcinoma (SCC) is a common...

2010-12-21 15:39:44

A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival. An increased number of circulating tumor cells (CTCs) also correlates with a worse outcome. Those are the early findings from an ongoing, prospective study of the prognostic importance of CTCs by a team of researchers at The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital...

2010-12-20 21:09:26

Patients who have recurrence of oral squamous cell carcinoma tend to do worse if the new cancer appears at the same site early or if it appears in the lymph nodes six months or longer after initial treatment, according to a report in the December issue of Archives of Otolaryngology"“Head & Neck Surgery, one of the JAMA/Archives journals. Treating recurrences of oral squamous cell carcinoma (cancer in the thin, flat cells that line the lips and mouth) involves balancing the risk of...

efa83c5cafaf4c3bc5304f57d6d835ef
2010-12-02 12:11:43

Reduction Greater than Achieved through Sunscreen A widely used arthritis drug reduces the incidence of non-melanoma skin cancers "“ the most common cancers in humans "“ according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults, led to a 62 percent reduction in non-melanoma skin cancers,...

2010-11-30 21:58:02

New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease. The researchers, led by University of Alabama at Birmingham senior scientist and the study's lead author, Craig Elmets, M.D., co-leader of the UAB Comprehensive Cancer Center 's Chemoprevention Program, evaluated the efficacy and safety of celecoxib as a chemo-preventive agent for actinic...

2010-11-20 00:00:52

Head-to-toe skin exams, at home and in your dermatologist's office, can save your life Roslyn, NY (PRWEB) November 19, 2010 Skin cancer is a scary subject. "No one wants to think about developing a disfiguring, even deadly, disease, therefore so many Americans live in a state of denial," says Joshua Fox, M.D., a leading dermatologist and medical director of Advanced Dermatology of New York and New Jersey. "Most people know they are supposed to be checking their skin monthly for changes...